4//SEC Filing
HARVARD BIOSCIENCE INC 4
Accession 0001209191-17-036311
$HBIOCIK 0001123494operating
Filed
May 29, 8:00 PM ET
Accepted
May 30, 8:49 PM ET
Size
8.0 KB
Accession
0001209191-17-036311
Insider Transaction Report
Form 4
Sun Yong
VP - Strategic Marketing
Transactions
- Award
Common Stock
2017-05-25+109,130→ 217,887 total - Award
Stock option (right to buy)
2017-02-06+10,000→ 10,000 totalExercise: $3.25Exp: 2027-02-06→ Common Stock, par value $0.01 per share (10,000 underlying)
Footnotes (3)
- [F1]Represents a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021.
- [F2]Includes (a) a deferred stock award of 109,130 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 66,755 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 8,612 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 14,058 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 19,332 shares of common stock held by the Reporting Person.
- [F3]The options vest in four equal installments on February 6, 2018, 2019, 2020 and 2021.
Documents
Issuer
HARVARD BIOSCIENCE INC
CIK 0001123494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001123494
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 8:49 PM ET
- Size
- 8.0 KB